Tissue immunostaining of growth, pro- and anti-apoptotic biomarkers in myocardial samples from newborns with hypoxic injury

Conclusion: These data seem to strengthen the coordinated action of the pro-apoptotic, anti-apoptotic and cell growth biomarkers in the myocardium of hypoxic newborns in order to determine the degree of lesion or cell death and the tissue recovery capacity.RESUMO Introdu ção: Apesar da importância de novas descobertas em patofisiologia das doenças cardiovasculares para a saúde da população, ainda existe pouco conhecimento sobre como a hipóxia neonatal, relacionada ou não com a prematuridade, pode causar lesão celular nos cardiomiócitos no período perinat al e quais são as consequências para a vida adulta. Objetivo: Analisar a imunoexpressão tecidual de biomarcadores envolvidos no processo de morte e crescimento celular em miocárdio de recém-nascidos hipoxemiados. Método: Amostras de miocárdio humano (ventrículo esquerdo), provenientes de n ecrópsias de neonatos hipoxemiados, foram organizadas em blocos multiamostrais e submetidas a reações imuno-histoquímicas pela técnica da imunoperoxidase. Os anticorpos primários utilizados foram antilinfoma de células B tipo 2 (Bcl2), antiproteína X associada ao Bcl2 (BAX), antimitofusina 2 (Mfn2), antiproteína 1 relacionada com o receptor ao fator de necrose tumoral (TRAP1), antiangiotensina II, antiproteína quinase 1 (Akt1), antiprot...
Source: Jornal Brasileiro de Patologia e Medicina Laboratorial - Category: Pathology Source Type: research

Related Links:

Publication date: Available online 17 July 2019Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Fernando Cabanillas, Noridza Rivera, Mirelis Acosta, Wandaly Pardo, Pedro Solivan, Caroline Rivera, Idalia LiboyAbstractBackgroundOur objective was to evaluate the impact of lenalidomide in patients with aggressive lymphoma who attained
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Tags: Research article Source Type: research
(Northwestern University) Many of the deadliest or most common cancers get the least amount of nonprofit research funding, reports a new Northwestern Medicine study. 'Embarrassing' or stigmatized cancers, like lung and liver, are underfunded. Colon, endometrial, liver and bile duct, cervical, ovarian, pancreatic and lung cancers were all poorly funded compared to how common they are and how many deaths they cause, the study found. In contrast, breast cancer, leukemia, lymphoma and pediatric cancers were all well-funded, respective to their impact on society.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Lymphoma - What is the role of diagnostic testing cytogenetics in 2016 Author: cancergrace Added: 07/17/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
Author: cancergrace Added: 07/17/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
Authors: Abstract [This corrects the article on p. 3 in vol. 54, PMID: 30956955.]. PMID: 31309098 [PubMed - in process]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research
Authors: Eskandari M, Manoochehrabadi S, Pashaiefar H, Zaimy MA, Ahmadvand M Abstract Background: Cell-free DNA (cfDNA) has the potential to serve as a non-invasive prognostic biomarker in some types of neoplasia. The investigation of plasma concentration of cfDNA may reveal its use as a valuable biomarker for risk stratification of diffuse large B-cell lymphoma (DLBCL). The present prognostic value of plasma cfDNA has not been widely confirmed in DLBCL subjects. Here, we evaluated cfDNA plasma concentration and assessed its potential prognostic value as an early DLBCL diagnostic tool. Methods: cfDNA concentrat...
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research
Conclusion: Our study showed that bendamustine is a potentially toxic agent in the conditioning regimen for autologous SCT, resulting in significant liver, kidney, and gastrointestinal toxicity. Further studies are required to assess its safety and efficacy at reduced doses. PMID: 31309088 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research
This study aimed to investigate the transcript dynamics of PLK1 and determine its role in the pathophysiology of MDS. Methods: PLK1 mRNA obtained from the bone marrow samples of 67 patients with MDS, 16 patients with secondary acute myeloid leukemia (sAML), and 10 healthy controls were analyzed using quantitative real-time PCR and compared according to various clinical parameters. Results: The median PLK1 expression levels differed slightly, but not significantly, between MDS and sAML patients [661.21 (range, 29.38-8,987.31) vs. 1,462.05 (32.22-5,734.09), respectively], but were significantly higher (P
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research
Authors: Sung YN, Huh J PMID: 31309083 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research
More News: Cardiology | Cardiovascular | Heart | Lymphoma | Perinatology & Neonatology | Study